Ms Celeste O'Callaghan:

There is engagement with patient advocacy groups and representatives in a number of different fora by the Department. While I do not have the full list of those to hand, there are patient representatives on various key groups. Bringing patient advocacy groups and representatives into the policy-making process is always an important feature.